Literature DB >> 26408359

The importance of hemoglobin A2 determination.

Maria Stella Figueiredo1.   

Abstract

Entities:  

Year:  2015        PMID: 26408359      PMCID: PMC4685102          DOI: 10.1016/j.bjhh.2015.06.002

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN: 1516-8484


× No keyword cloud information.
Hemoglobin (Hb) A2 (α2δ2) constitutes less than 3% of the total hemoglobin (Hb) in adults and has almost no physiological importance. On the other hand, the determination of Hb A2 is an important tool to diagnose the beta-thalassemia trait (BTT).1, 2 Although individuals with BTT do not need treatment, the accurate detection of the carrier state is important in genetic counseling to determine risk of having a child with a major disease. Elevated levels of Hb A2 and microcytosis are suggestive of the diagnosis of BTT. However, BTT may be present with normal levels of Hb A2 as a few cases of β-thalassemia are not associated with elevated Hb A2, and because of the association of BTT with iron deficiency or with α-thalassemia (α-Thal).1, 2, 4, 5, 6 There are many other factors, inherited or acquired, that can interfere in Hb A2 levels (Table 1).3, 4
Table 1

Causes of variation in the percentage of hemoglobin A2.

Hb A2InheritedAcquired
Increased (>3.4%)β-Thalassemia heterozygosityDeletional HPFH from Vietnamese/South East AsianHereditary high Hb A2Unstable hemoglobinSickle cell traitSickle cell anemia (particularly coexisting α-thalassemia)Hb S/β0-thalassemiaCongenital dyserythropoietic anemia (some cases)Heterozygosity for other β-chain variantsThyrotoxicosisHIV infectionZidovudine therapyMegaloblastic anemia (some cases)



Decreased (<2.2%)α-thalassemia: α+ homozygosity, a0 heterozygosity, and HbH diseaseDeletional HPFH (except Vietnamese/South East Asian type)δβ and Aγδβ-thalassemia heterozygosity (some cases)δ-ThalassemiaHemoglobin LeporeHemoglobin KenyaSevere iron deficiencyAnemia of chronic diseaseSideroblastic anemiaLead poisoningJuvenile myelomonocytic leukemiaAcquired Hb H diseaseAcute myeloid leukemia (some cases, particularly erythroleukemia)Aplastic anemia (some cases)HypothyroidismChemotherapy-induced increased Hb F synthesis

Hb A2 – hemoglobin A2; HPFH: hereditary persistence of fetal hemoglobin; HIV: human immunodeficiency virus; HbH: hemoglobin H; Hb F: hemoglobin F or fetal hemoglobin.

Hb A2 can be measured by several laboratorial methods, but these methods have differences in accuracy. Cation exchange high performance liquid chromatography (HPLC), microcolumn chromatography, and cellulose acetate electrophoresis with elution are considered acceptable methods to diagnose BTT, whereas cellulose acetate electrophoresis followed by scanning densitometry is not. The accuracy of cellulose acetate electrophoresis with elution depends on the training and experience of the laboratory technician who performs the test, and microcolumn chromatography can give problems with co-elution of some Hb variants. Recent studies have confirmed the higher quality of automated HPLC in the measurement of Hb A2 compared to the other methods,8, 9 which is why this has become the method of choice. On the other hand, in automated HPLC, the measurement of Hb A2 is inaccurate when Hb S is present.2, 3, 10 As the amount of Hb S is related to the degree of inaccuracy, levels are higher in patients with sickle cell anemia (SCA) or Hb S/β-thalassemia (S-βThal) than in sickle cell trait. Thus, the amount of Hb A2 does not indicate BTT when Hb A and beta gene variants are found together. Furthermore, when beta gene variants are present without Hb A, the diagnosis of concomitant BTT is not necessarily associated to the elevation of Hb A2 and so further investigations using family studies or DNA analysis are necessary. As mentioned above, α-Thal is capable of interfering in the determination of Hb A2. Individuals with the α0-thalassemia trait or homozygous for α+-thalassemia have lower levels of Hb A2, but the influence of the coinheritance of α-Thal and BTT on Hb A2 levels is uncertain. In Brazil, the incidence of α-Thal varies from 0.11 to 0.22% depending on the geographical region studied.12, 13, 14, 15 It is well known that the association of α-Thal and SCA is common in Brazil.16, 17, 18 Since SCA is considered a public health problem in Brazil and due to the clinical significance of α-Thal in respect to this anemia, diagnosis is important.19, 20, 21 However, diagnosis is mainly achieved by molecular techniques that are expensive and not easily accessible. It is also important to remember that the co-inheritance of α-Thal and SCA results in increased levels of Hb A2 as measured by automated HPLC, and could result in a misdiagnosis of S-βThal. There lies the importance of the paper entitled “Hemoglobin A2 values quantified by high performance liquid chromatography in patients with sickle cell disease, and the influence of the presence of alpha-thalassemia” written by Fonseca et al. and published in this edition of the Revista Brasileira de Hematologia e Hemoterapia. The authors demonstrate that Hb A2 was overestimated not only in individuals with Hb S but also in patients with Hb C, and that the Hb A2 level was influenced by the genotype of α-Thal. In conclusion, in a country with a high degree of miscegenation such as Brazil, not only the diagnosis of double heterozygous states, such as S-βThal, but also the diagnosis of co-inheritance of SCA with α-Thal should be carried out carefully, taking into consideration the limitations of the available laboratory techniques. Family studies or DNA analysis, when possible, are desirable to confirm the correct diagnosis.

Conflicts of interest

The authors declare no conflicts of interest.
  21 in total

1.  Editorial: measurement of HbA2.

Authors:  Piero C Giordano
Journal:  Int J Lab Hematol       Date:  2012-02-16       Impact factor: 2.877

2.  Effect of HbS in the determination of HbA2 with the Menarini HA-8160 analyzer and comparison with other instruments.

Authors:  K Anagnostopoulos; I Tentes; C Kalleas; D Margaritis; A Toli; D Pendilas; G Bourikas; C Tsatalas; A H Kortsaris
Journal:  Int J Lab Hematol       Date:  2008-08-07       Impact factor: 2.877

Review 3.  Hemoglobin A2: origin, evolution, and aftermath.

Authors:  M H Steinberg; J G Adams
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113

4.  Effects of α-thalassaemia mutations on the haematological parameters of β-thalassaemia carriers.

Authors:  Nasrollah Saleh-Gohari; Maryam Khademi Bami; Roya Nikbakht; Hassan Karimi-Maleh
Journal:  J Clin Pathol       Date:  2015-05-02       Impact factor: 3.411

5.  Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.

Authors:  M Shokrani; F Terrell; E A Turner; M D Aguinaga
Journal:  Ann Clin Lab Sci       Date:  2000-04       Impact factor: 1.256

6.  Clinical, hematological, and molecular characterization of sickle cell anemia pediatric patients from two different cities in Brazil.

Authors:  Isa Menezes Lyra; Marilda Souza Gonçalves; Joseffina A Pellegrinei Braga; Maria de Fátima Gesteira; Maria Helena Carvalho; Sara Terezinha Olalla Saad; Maria Stella Figueiredo; Fernando Ferreira Costa
Journal:  Cad Saude Publica       Date:  2005-07-11       Impact factor: 1.632

7.  [Sickle cell disease as a public health problem in Brazil].

Authors:  R B de Paiva e Silva; A S Ramalho; R M Cassorla
Journal:  Rev Saude Publica       Date:  1993-02       Impact factor: 2.106

8.  Prevalence of α-thalassemia 3.7 kb deletion in the adult population of Rio Grande do Norte, Brazil.

Authors:  Gustavo Henrique de Medeiros Alcoforado; Christiane Medeiros Bezerra; Telma Maria Araújo Moura Lemos; Denise Madureira de Oliveira; Elza Miyuki Kimura; Fernando Ferreira Costa; Maria de Fátima Sonati; Tereza Maria Dantas de Medeiros
Journal:  Genet Mol Biol       Date:  2012-07-26       Impact factor: 1.771

9.  Hemoglobin A2 Lowered by Iron Deficiency and α -Thalassemia: Should Screening Recommendation for β -Thalassemia Change?

Authors:  Srdjan Denic; Mukesh M Agarwal; Bayan Al Dabbagh; Awad El Essa; Mohamed Takala; Saad Showqi; Javed Yassin
Journal:  ISRN Hematol       Date:  2013-03-12

10.  Hemoglobin A2 values in sickle cell disease patients quantified by high performance liquid chromatography and the influence of alpha thalassemia.

Authors:  Silvana Fahel da Fonseca; Tatiana Amorim; Antônio Purificação; Marilda Gonçalves; Ney Boa-Sorte
Journal:  Rev Bras Hematol Hemoter       Date:  2015-06-07
View more
  5 in total

1.  Paper-based microchip electrophoresis for point-of-care hemoglobin testing.

Authors:  Muhammad Noman Hasan; Arwa Fraiwan; Ran An; Yunus Alapan; Ryan Ung; Asya Akkus; Julia Z Xu; Amy J Rezac; Nicholas J Kocmich; Melissa S Creary; Tolulope Oginni; Grace Mfon Olanipekun; Fatimah Hassan-Hanga; Binta W Jibir; Safiya Gambo; Anil K Verma; Praveen K Bharti; Suchada Riolueang; Takdanai Ngimhung; Thidarat Suksangpleng; Priyaleela Thota; Greg Werner; Rajasubramaniam Shanmugam; Aparup Das; Vip Viprakasit; Connie M Piccone; Jane A Little; Stephen K Obaro; Umut A Gurkan
Journal:  Analyst       Date:  2020-03-03       Impact factor: 4.616

2.  [Screening and verification of plasma biomarkers for stable angina pectoris: a differential proteomic analysis].

Authors:  An-Na Shen; Shui-Wang Hu; Jing Huang; De-Zhong Zheng; Zhao-Ting Hu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-10-20

Review 3.  Techniques for the Detection of Sickle Cell Disease: A Review.

Authors:  Wjdan A Arishi; Hani A Alhadrami; Mohammed Zourob
Journal:  Micromachines (Basel)       Date:  2021-05-05       Impact factor: 2.891

4.  Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity.

Authors:  Muhammed Emin Ozcan; Bahri Ince; Hasan Huseyin Karadeli; Asuman Gedikbasi; Talip Asil; Meric A Altinoz
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-16       Impact factor: 2.570

5.  Nationwide carrier detection and molecular characterization of β-thalassemia and hemoglobin E variants in Bangladeshi population.

Authors:  Farjana Akther Noor; Nusrat Sultana; Golam Sarower Bhuyan; Md Tarikul Islam; Mohabbat Hossain; Suprovath Kumar Sarker; Khaleda Islam; Waqar Ahmed Khan; Mujahida Rahman; Syeda Kashfi Qadri; Hossain Uddin Shekhar; Firdausi Qadri; Syed Saleheen Qadri; Kaiissar Mannoor
Journal:  Orphanet J Rare Dis       Date:  2020-01-15       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.